ZA883135B - Oral forms of administration with delayed release - Google Patents
Oral forms of administration with delayed releaseInfo
- Publication number
- ZA883135B ZA883135B ZA883135A ZA883135A ZA883135B ZA 883135 B ZA883135 B ZA 883135B ZA 883135 A ZA883135 A ZA 883135A ZA 883135 A ZA883135 A ZA 883135A ZA 883135 B ZA883135 B ZA 883135B
- Authority
- ZA
- South Africa
- Prior art keywords
- administration
- delayed release
- oral forms
- forms
- carbamazepine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Pain & Pain Management (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Cosmetics (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH168287 | 1987-05-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA883135B true ZA883135B (en) | 1988-11-07 |
Family
ID=4216129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA883135A ZA883135B (en) | 1987-05-04 | 1988-05-03 | Oral forms of administration with delayed release |
Country Status (21)
Country | Link |
---|---|
US (1) | US5122543A (no) |
EP (1) | EP0289977B1 (no) |
JP (1) | JPH01131117A (no) |
KR (1) | KR960006059B1 (no) |
AT (1) | ATE94390T1 (no) |
AU (1) | AU619178B2 (no) |
CA (1) | CA1328219C (no) |
DD (1) | DD269784A5 (no) |
DE (1) | DE3884044D1 (no) |
DK (1) | DK169608B1 (no) |
ES (1) | ES2043716T3 (no) |
FI (1) | FI882044A (no) |
HU (1) | HU199074B (no) |
IE (1) | IE63081B1 (no) |
IL (1) | IL86211A (no) |
MX (1) | MX11339A (no) |
NO (1) | NO881933L (no) |
NZ (1) | NZ224476A (no) |
PH (1) | PH24895A (no) |
PT (1) | PT87381B (no) |
ZA (1) | ZA883135B (no) |
Families Citing this family (34)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
US5676968A (en) * | 1991-10-31 | 1997-10-14 | Schering Aktiengesellschaft | Transdermal therapeutic systems with crystallization inhibitors |
DE4210711A1 (de) * | 1991-10-31 | 1993-05-06 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Transdermale therapeutische systeme mit kristallisationsinhibitoren |
DE4422881A1 (de) * | 1993-10-25 | 1995-04-27 | Bayer Ag | Kolloidal dispergierbare Wirkstoff-Formulierungen |
DE69535127T2 (de) * | 1994-03-18 | 2007-02-15 | Supernus Pharmaceuticals, Inc. | Emulgierte arzneistoffabgabesysteme |
DE4423078B4 (de) * | 1994-07-01 | 2005-01-13 | Awd.Pharma Gmbh & Co. Kg | Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung |
AU749301B2 (en) * | 1997-12-19 | 2002-06-20 | Taro Pharmaceutical Industries Ltd. | Topical carbamazepine formulations and methods of use |
GB9930058D0 (en) * | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
US6884436B2 (en) * | 2000-12-22 | 2005-04-26 | Baxter International Inc. | Method for preparing submicron particle suspensions |
US20050048126A1 (en) * | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
US7037528B2 (en) * | 2000-12-22 | 2006-05-02 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US20030072807A1 (en) * | 2000-12-22 | 2003-04-17 | Wong Joseph Chung-Tak | Solid particulate antifungal compositions for pharmaceutical use |
US6977085B2 (en) * | 2000-12-22 | 2005-12-20 | Baxter International Inc. | Method for preparing submicron suspensions with polymorph control |
US6951656B2 (en) * | 2000-12-22 | 2005-10-04 | Baxter International Inc. | Microprecipitation method for preparing submicron suspensions |
US8067032B2 (en) * | 2000-12-22 | 2011-11-29 | Baxter International Inc. | Method for preparing submicron particles of antineoplastic agents |
US20040256749A1 (en) * | 2000-12-22 | 2004-12-23 | Mahesh Chaubal | Process for production of essentially solvent-free small particles |
US9700866B2 (en) * | 2000-12-22 | 2017-07-11 | Baxter International Inc. | Surfactant systems for delivery of organic compounds |
AU2002249836B2 (en) * | 2000-12-22 | 2006-12-14 | Baxter International Inc. | Method for preparing submicron particle suspensions |
US20040022862A1 (en) * | 2000-12-22 | 2004-02-05 | Kipp James E. | Method for preparing small particles |
US7193084B2 (en) * | 2000-12-22 | 2007-03-20 | Baxter International Inc. | Polymorphic form of itraconazole |
IN190699B (no) | 2001-02-02 | 2003-08-16 | Sun Pharmaceutical Ind Ltd | |
US20060003012A9 (en) * | 2001-09-26 | 2006-01-05 | Sean Brynjelsen | Preparation of submicron solid particle suspensions by sonication of multiphase systems |
MXPA04002446A (es) * | 2001-09-26 | 2004-07-23 | Baxter Int | Preparacion de nanoparticulas de tamano de submicras mediante dispersion y remocion de la fase liquida o solvente. |
US7112340B2 (en) * | 2001-10-19 | 2006-09-26 | Baxter International Inc. | Compositions of and method for preparing stable particles in a frozen aqueous matrix |
WO2003075830A2 (en) * | 2002-03-14 | 2003-09-18 | Sun Pharmaceutical Industries Limited | Oral controlled drug delivery system containing carbamazepine |
MX2007015183A (es) * | 2005-06-14 | 2008-02-19 | Baxter Int | Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco. |
US20060280787A1 (en) * | 2005-06-14 | 2006-12-14 | Baxter International Inc. | Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof |
BRPI0618661A2 (pt) * | 2005-11-15 | 2011-09-06 | Baxter Int | composições de inibidores de lipoxigenase |
US20090152176A1 (en) * | 2006-12-23 | 2009-06-18 | Baxter International Inc. | Magnetic separation of fine particles from compositions |
US8722736B2 (en) * | 2007-05-22 | 2014-05-13 | Baxter International Inc. | Multi-dose concentrate esmolol with benzyl alcohol |
US20080293814A1 (en) * | 2007-05-22 | 2008-11-27 | Deepak Tiwari | Concentrate esmolol |
US8426467B2 (en) * | 2007-05-22 | 2013-04-23 | Baxter International Inc. | Colored esmolol concentrate |
US9394327B1 (en) * | 2013-03-15 | 2016-07-19 | The Trustees Of California State University | Nucleoside crystals, crystal nucleation and growth control with antifreeze proteins |
CA2967287A1 (en) * | 2014-11-18 | 2016-05-26 | PixarBio Corporation | Compositions for treating acute, post-operative, or chronic pain and methods of using the same |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2861920A (en) * | 1954-05-04 | 1958-11-25 | Upjohn Co | Therapeutic suspensions of steroids containing pvp and/or pva |
US4213963A (en) * | 1978-12-14 | 1980-07-22 | Janssen Pharmaceutica N.V. | Fluspirilene-containing compositions |
US4431641A (en) * | 1980-10-17 | 1984-02-14 | Ciba-Geigy Corporation | Pharmaceutical compositions having antiepileptic and antineuralgic action |
CH649080A5 (de) * | 1981-04-16 | 1985-04-30 | Ciba Geigy Ag | 5h-dibenz(b,f)azepin-5-carboxamide als mittel zur prophylaxe und behandlung von zerebraler leistungsinsuffizienz. |
JPS59147374A (ja) * | 1983-02-10 | 1984-08-23 | Fuji Xerox Co Ltd | 電子写真複写機のブラシクリ−ニング方法 |
DE3306250A1 (de) * | 1983-02-23 | 1984-08-23 | Basf Ag, 6700 Ludwigshafen | Sphaerische einkristalle fuer pharmazeutische zwecke |
US4548990A (en) * | 1983-08-15 | 1985-10-22 | Ciba-Geigy Corporation | Crosslinked, porous polymers for controlled drug delivery |
DE3686085T2 (de) * | 1985-05-02 | 1993-01-07 | Ciba Geigy Ag | Hydrogele mit erhoehter beladungskapazitaet bezueglich einer in einem organischen loesungsmittel loeslichen wirksubstanz, deren herstellung sowie deren verwendung. |
CH668187A5 (de) * | 1986-08-07 | 1988-12-15 | Ciba Geigy Ag | Therapeutisches system mit systemischer wirkung. |
JPH0641286B2 (ja) * | 1987-05-14 | 1994-06-01 | 信行 西井 | 自動包装装置 |
US4964606A (en) * | 1989-10-26 | 1990-10-23 | Ncr Corporation | Overhead mount for a CRT |
-
1988
- 1988-04-28 IL IL86211A patent/IL86211A/xx unknown
- 1988-04-30 JP JP63105539A patent/JPH01131117A/ja active Pending
- 1988-05-02 FI FI882044A patent/FI882044A/fi not_active Application Discontinuation
- 1988-05-02 MX MX1133988A patent/MX11339A/es unknown
- 1988-05-02 ES ES88107021T patent/ES2043716T3/es not_active Expired - Lifetime
- 1988-05-02 EP EP88107021A patent/EP0289977B1/de not_active Expired - Lifetime
- 1988-05-02 CA CA000565638A patent/CA1328219C/en not_active Expired - Fee Related
- 1988-05-02 PT PT87381A patent/PT87381B/pt not_active IP Right Cessation
- 1988-05-02 AT AT88107021T patent/ATE94390T1/de not_active IP Right Cessation
- 1988-05-02 DE DE88107021T patent/DE3884044D1/de not_active Expired - Fee Related
- 1988-05-02 DD DD88315309A patent/DD269784A5/de not_active IP Right Cessation
- 1988-05-03 KR KR1019880005130A patent/KR960006059B1/ko active IP Right Grant
- 1988-05-03 IE IE132888A patent/IE63081B1/en not_active IP Right Cessation
- 1988-05-03 DK DK238888A patent/DK169608B1/da not_active IP Right Cessation
- 1988-05-03 HU HU882254A patent/HU199074B/hu not_active IP Right Cessation
- 1988-05-03 ZA ZA883135A patent/ZA883135B/xx unknown
- 1988-05-03 NZ NZ224476A patent/NZ224476A/xx unknown
- 1988-05-03 NO NO881933A patent/NO881933L/no unknown
- 1988-05-04 PH PH36892A patent/PH24895A/en unknown
- 1988-05-04 AU AU15558/88A patent/AU619178B2/en not_active Ceased
-
1989
- 1989-12-14 US US07/453,103 patent/US5122543A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
PT87381A (pt) | 1989-05-31 |
PT87381B (pt) | 1992-08-31 |
MX11339A (es) | 1993-12-01 |
PH24895A (en) | 1990-12-26 |
FI882044A (fi) | 1988-11-05 |
DE3884044D1 (de) | 1993-10-21 |
IE881328L (en) | 1988-11-04 |
IL86211A (en) | 1992-03-29 |
CA1328219C (en) | 1994-04-05 |
AU619178B2 (en) | 1992-01-23 |
KR880013550A (ko) | 1988-12-21 |
FI882044A0 (fi) | 1988-05-02 |
HUT46847A (en) | 1988-12-28 |
NO881933L (no) | 1988-11-07 |
NO881933D0 (no) | 1988-05-03 |
DK238888A (da) | 1988-11-05 |
ES2043716T3 (es) | 1994-01-01 |
US5122543A (en) | 1992-06-16 |
DK238888D0 (da) | 1988-05-03 |
DK169608B1 (da) | 1994-12-27 |
ATE94390T1 (de) | 1993-10-15 |
KR960006059B1 (ko) | 1996-05-08 |
EP0289977A1 (de) | 1988-11-09 |
EP0289977B1 (de) | 1993-09-15 |
HU199074B (en) | 1990-01-29 |
NZ224476A (en) | 1990-09-26 |
IE63081B1 (en) | 1995-03-22 |
DD269784A5 (de) | 1989-07-12 |
AU1555888A (en) | 1988-11-10 |
IL86211A0 (en) | 1988-11-15 |
JPH01131117A (ja) | 1989-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA883135B (en) | Oral forms of administration with delayed release | |
NO880950D0 (no) | Fremgangsmaate for fremstilling av oksygen med hoey renhet. | |
EP0313053A3 (en) | Liquid crystal devices and process for producing the same | |
GB2208486B (en) | Joining single crystal and polycrystalline superalloy articles. | |
AU7070887A (en) | Method for forming crystals | |
AU7070387A (en) | Single crystal articles having reduced anisotropy | |
GB8827277D0 (en) | Process for producing liquid crystal devices | |
EP0279611A3 (en) | Process for producing high modulus film | |
AU2045188A (en) | Crystal article, method for producing the same and semiconductor device utilizing the same | |
EP0401387A4 (en) | Process for producing single crystal | |
NO884416D0 (no) | Krystallinsk beta-laktamhydrat og fremgangsmaate for fremstilling derav. | |
AU3175689A (en) | Method for forming crystal | |
AU3126084A (en) | Crystal oscillator amplification | |
EP0300168A3 (en) | Process for the glutathione synthesis in yeast | |
IL85807A0 (en) | Crystal growing apparatus | |
GB2191113B (en) | Device for growing single crystals. | |
MY103367A (en) | Oral forms of administration with delayed release | |
EP0284088A3 (en) | Process for producing superconducting thick film | |
EP0245510A4 (en) | DEVICE FOR PRODUCING A MONOCRISTAL SEMICONDUCTOR. | |
EP0321572A4 (en) | PREGNANE DERIVATIVES AND PREPARATION METHOD. | |
GB2159433B (en) | Chrysoberyl single crystal showing iridescent effect and process for its preparation | |
HUT47645A (en) | Process for producing 1-methyl-1,4-androstadien-3,17-dione | |
AR243231A1 (es) | Procedimiento para producir medios de cultivo. | |
NO892107D0 (no) | Fremgangsmaate for fremstilling av laktulosesirup med hoey renhetsgrad. | |
JPS6419074A (en) | Liquid crystal 3- and/or 9-substituted 1,5-dihetrospiro(5,5)undecane |